Vardaan Infertility & Medical Research Center Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 27-06-2024
- Paid Up Capital ₹ 1.00 Cr
as on 27-06-2024
- Company Age 16 years 4 months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.88 Cr
as on 27-06-2024
- Satisfied Charges ₹ 0.14 Cr
as on 27-06-2024
- Revenue 2.48%
FY 2020
- Profit -1.83%
FY 2020
- Ebitda 31.40%
FY 2020
- Net Worth 10.56%
FY 2020
- Total Assets 2.76%
FY 2020
About Vardaan Infertility & Medical Research Center
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The Corporate currently has active open charges totaling ₹1.88 Cr. It has already closed loans amounting to ₹1.35 M, as per the Ministry of Corporate Affairs (MCA) records.
Anu Huria and Vareesh Huria serve as directors at the Company.
- CIN/LLPIN
U85110PB2008PTC031971
- Company No.
031971
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 May 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Jalandhar, Punjab, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Vardaan Infertility & Medical Research Center?
Executive Team (1)
VH
Vareesh Huria
Managing DirectorAppointment Date: 30-May-2008
Status: Current
Financial Performance and Corporate Structure Insights of Vardaan Infertility & Medical Research Center.
Vardaan Infertility & Medical Research Center Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 2.48% increase. The company also saw a slight decrease in profitability, with a 1.83% decrease in profit. The company's net worth Soared by an impressive increase of 10.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| FY 2022 | FY 2021 | FY 2020 | FY 2019 | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vardaan Infertility & Medical Research Center?
In 2019, Vardaan Infertility & Medical Research Center had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 23 Sep 2022 | ₹1.00 Cr | Open |
Hdfc Bank Limited Creation Date: 15 Jul 2021 | ₹7.80 M | Open |
Others Creation Date: 16 May 2018 | ₹1.00 M | Open |
How Many Employees Work at Vardaan Infertility & Medical Research Center?
Vardaan Infertility & Medical Research Center has a workforce of 33 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of Apr 03, 2015, Vardaan Infertility & Medical Research Center has raised a total of ₹ 9.9 M, with the most recent deal valued at ₹ 9.9 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
